85 firms are involved in providing fragment-based drug discovery-related services

Jordan12

288
views

According to experts in this field, fragment-based drug discovery solutions have facilitated the identification of viable pharmacological leads against otherwise hard to target biomolecules

According to experts in this field, fragment-based drug discovery solutions have facilitated the identification of viable pharmacological leads against otherwise hard to target biomolecules. In fact, many service provider companies are offering fragment libraries and support to the medical research community in order to develop an appropriate intervention to treat the illness caused by the SARS-CoV-2 virus.

To order this 170+ page report, which features 55+ figures and 80+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html

The USD 1.6 billion (by 2030) financial opportunity within the fragment-based drug discovery market has been analyzed across the following segments:

Type of Screening Technique Used
X-ray Crystallography
Nuclear Magnetic Resonance
Surface Plasmon Resonance
Other Screening Techniques

Type of Service Offered
Library Screening
Fragment Screening
Fragment Optimization

End User
Industry Players
Non-Industry Players

Key geographical regions
North America (US and Canada)
Europe (UK, France, Germany, Spain, Italy, and rest of Europe)
Asia-Pacific (China, Japan, India, and rest of Asia-Pacific / rest of the world)

The “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030 report features the following companies, which we identified to be key players in this domain:

2bind
Charles River Laboratories
ChemAxon
ComInnex
Creative Biolabs
Creative Biostructure
CRELUX
Domainex
Evotec
Red Glead Discovery
SARomics Biostructures
Shanghai ChemPartner
Sygnature Discovery
Vernalis Research

Table of Contents

Press Release: Variation 3 (Format 4)

Preface

2. Executive Summary
Introduction
Current Market Landscape
Company Profiles: Fragment-based Drug Discovery Library and Service Providers
Partnerships and Collaborations
Key Acquisition Targets
Company Competitiveness Analysis
Cost Saving Analysis
Market Forecast and Opportunity Analysis
Executive Insights

Concluding Remarks

Appendix 1: Tabulated Data

Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

Accordingto experts in this field, fragment-based drug discovery solutions havefacilitated the identification of viable pharmacological leads againstotherwise hard to target biomolecules. In fact, many service provider companiesare offering fragment libraries and support to the medical research communityin order to develop an appropriate intervention to treat the illness caused bythe SARS-CoV-2 virus.

To order this 170+ pagereport, which features 55+ figures and 80+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html

The USD 1.6 billion (by 2030) financial opportunity within thefragment-based drug discovery market has been analyzed across the followingsegments:

§ Type of ScreeningTechnique Used

§ X-ray Crystallography

§ Nuclear Magnetic Resonance

§ Surface PlasmonResonance

§ Other ScreeningTechniques

§ Type of Service Offered

§ Library Screening

§ Fragment Screening

§ Fragment Optimization

§ End User

§ Industry Players

§ Non-Industry Players

§ Key geographicalregions

§ North America (US andCanada)

§ Europe (UK, France,Germany, Spain, Italy, and rest of Europe)

§ Asia-Pacific (China,Japan, India, and rest of Asia-Pacific / rest of the world)

The “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030 report features thefollowing companies, which we identified to be key players in this domain:

§ 2bind

§ Charles River Laboratories

§ ChemAxon

§ ComInnex

§ Creative Biolabs

§ Creative Biostructure

§ CRELUX

§ Domainex

§ Evotec

§ Red Glead Discovery

§ SARomics Biostructures

§ Shanghai ChemPartner